RxDoctor Payments Data

Jamie Arnold, DO

Psychiatry · East Lansing, MINPI 1568757714

Payments from drug & device makers

$429in general payments, 2019–2025

Across 23 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$100
  • Neurocrine Biosciences, Inc.$92
  • Johnson & Johnson$61
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
  • Otsuka America Pharmaceutical, Inc.$41
  • Indivior Inc.$25
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$38289%
  • Education$4711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$429 in reported general payments places this provider in the 60th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$32,623
Medicare patients
136
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole83$231,954
IngrezzaValbenazine Tosylate26$218,244
Invega TrinzaPaliperidone Palmitate19$166,528
Invega SustennaPaliperidone Palmitate38$115,076
AustedoDeutetrabenazine12$73,824
VraylarCariprazine Hcl20$47,288
Clozapine326$33,438
Lurasidone Hcl77$26,204
TrintellixVortioxetine Hydrobromide41$19,491
RexultiBrexpiprazole12$15,450
Paliperidone ErPaliperidone92$9,976
Olanzapine322$7,754
Fluphenazine Hcl67$6,337
Olanzapine OdtOlanzapine59$3,399
Benztropine Mesylate274$3,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$61$281,60557 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$41$247,40495 claims
Neurocrine Biosciences, Inc.Ingrezza$92$218,24426 claims
Teva Pharmaceuticals USA, Inc.Austedo, Loxapine$18$74,86824 claims
AbbVieVraylar$13$47,28820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →